Channel Avatar

Let's Talk Risk! @UCufMj5bcCrGJ5AKYTMk9irA@youtube.com

3.8K subscribers - no pronouns :c

Dear colleagues, hello 👋 If you are looking for practical


34:00
LTR 66: Understanding human factors aspect of augmented reality applications in medical devices
35:15
LTR 65: Demystifying risk-based approach vs. risk management
01:25
LTR 64: Opportunities and challenges to leverage PCCP for speed to market
35:51
LTR 63: A lawyer's perspective on the QMSR transition
30:49
LTR 62: Overcoming barriers to cross-functional communication and collaboration
39:24
LTR 61: Treat human factors as a driver of customer satisfaction, not a check-the-box activity
06:35
Medical Device Software Risk Management - Challenges and Tips
31:08
LTR 60: Defining state of the art can be challenging; here are a few tips.
32:14
LTR 59: FDA's pre-sub program and how it can accelerate medical device innovation
41:23
LTR 58: Tips for clinicians transitioning into a medical safety role in MedTech
02:39
Understanding terminology - SaMD, AI, ML
34:09
LTR 57: It's time to focus on supply chain resiliency not just supplier management
31:28
LTR 56: How to communicate effectively with senior management
02:16
Webinar: How to set up post-market surveillance for your medical device
33:18
LTR 54: Start your risk analysis by first defining the intended use
35:41
LTR 53: Three big trends to watch in MedTech
34:20
LTR 52: The key to success as a risk practitioner in the medical device industry.
01:36
Collaborate for success in risk management
35:17
LTR 50: Humility is the key to startup success
21:51
RM roundup #3: 10 noteworthy risk-related LinkedIn posts
06:53
Webinar: FDA warning letter case study
34:42
LTR 49: A clinician's view on AI/ML enabled medical devices
34:39
LTR 48: Integrating purchasing controls across product lifecycle
11:21
Webinar: How to create a master harms list using standard codes
33:22
LTR 46: Tips to boost effectiveness of medical device post-market surveillance
02:56
LTR Weekly Digest #31 - 6th April, 2024
31:23
LTR 45: A patient's perspective on CGMs
34:18
LTR 44: Why we need a new approach to learning medical software and medical AI
20:43
RM roundup #2: 10 noteworthy risk-related LinkedIn posts
38:15
LTR 43: Tips for integrating risk analysis with design controls
08:03
Webinar: Benefit-risk evaluation of an AI/ML enabled medical device
20:59
RM roundup #1: 10 of my favorite risk-related LinkedIn posts
02:19
State or event? A new way to think about the term Hazard.
33:55
LTR 42: State or event? Thinking clearly about hazards will help you manage risk.
42:02
LTR 40: A guest podcast with NAMSA - Part 1
02:12
How to create reliability targets using a risk-based approach
33:20
LTR 39: Overcoming challenges in linking risk management with design controls
01:53
Barriers to collaboration in risk management
34:59
LTR 38: How medical safety professionals can serve as culture brokers in MedTech
02:15
Why QMSR, why now?
08:18
Webinar: Getting Ready for QMSR
33:39
LTR 36: Why we should not overlook the quality-of-life benefit in risk evaluation
01:55
Why QA/RA professionals should embrace AI for career growth.
03:26
LTR Weekly Digest #19 - 13th January, 2024
34:29
LTR 35: Tips for improving collaboration in risk management
03:24
LTR Weekly Digest #18 - 6th January, 2024
32:45
LTR 34: Build a culture of Quality to achieve inspection-readiness at all times
06:35
Webinar: Why FMEA alone is not sufficient for risk analysis
38:01
LTR 33: AI and the future of work for QA/RA professionals
02:09
Use a risk-based approach to design connected medical devices
35:20
LTR 32: A new paradigm for building connected medical devices
33:37
LTR 31: Focus on the purpose to measure process effectiveness
01:40
There is more to risk analysis than FMEA
01:13
Simplify risk management to support innovation in diagnostic devices
35:05
LTR 30: It is time to unfake risk management!
02:06
Understand the difference between AI and ML
01:28
Build empathy to motivate and empower your team
01:47
Understand the link between clinical evaluation and state-of-the-art
02:15
Benefits of early clinical input in medical device design
01:20
Communicating regulatory risk in business terms